Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-Pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

Logo
☰
  • Services ⌄
    • Histology
    • Pharmacology
    • Medical Device Testing
    • In Vitro Screening
    • Animal Model Development
    • Custom Assay Development
    • Vivarium Rental
    • Toxicology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Mini-Pigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Career
    • Request a Quote

FDA Releases Final Guidance on Interoperable Devices

  • Post author:Sam
  • Post published:October 9, 2017
  • Post category:The GMP Letter

The FDA unveiled final recommendations for how medical devices should be designed to interact with other devices and IT systems. Source: The GMP Letter

Continue ReadingFDA Releases Final Guidance on Interoperable Devices

483 Roundup: FDA Cites Six Firms Over Complaints, Other Deficiencies

  • Post author:Sam
  • Post published:October 9, 2017
  • Post category:The GMP Letter

The FDA issued flagged six device manufacturers for issues ranging from responses to customer complaints to record-keeping. Source: The GMP Letter

Continue Reading483 Roundup: FDA Cites Six Firms Over Complaints, Other Deficiencies

Warning Letter Roundup: FDA Targets Five Devicemakers

  • Post author:Sam
  • Post published:October 9, 2017
  • Post category:The GMP Letter

The FDA issued warning letters to five device manufacturers for a range of issues, including a failure to seek pre-market approval, to apply for modified intended uses, and quality violations.…

Continue ReadingWarning Letter Roundup: FDA Targets Five Devicemakers

Protecting Devices From Cybersecurity Risks

  • Post author:Sam
  • Post published:October 9, 2017
  • Post category:The GMP Letter

With the recall of 465,000 Abbott pacemakers deemed at risk of getting hacked — marking the first ever device recall for a cybersecurity issue — it’s time for a deeper…

Continue ReadingProtecting Devices From Cybersecurity Risks

Court Agrees to New Trial Over Negligence Claims Against DePuy

  • Post author:Sam
  • Post published:October 9, 2017
  • Post category:The GMP Letter

The Cook County Circuit Court revived a 2013 lawsuit against DePuy Orthopaedics and Premier Orthopaedics Sales alleging negligence in designing a hip replacement device. Source: The GMP Letter

Continue ReadingCourt Agrees to New Trial Over Negligence Claims Against DePuy

Cyber Risk Prompts Abbott Recall of 465K Pacemakers

  • Post author:Sam
  • Post published:October 9, 2017
  • Post category:The GMP Letter

In the first ever recall for a cybersecurity risk, Abbott recalled 465,000 implantable pacemakers for a firmware update to reduce the risk of unauthorized access. The update requires an in-person…

Continue ReadingCyber Risk Prompts Abbott Recall of 465K Pacemakers

EpiPen Manufacturer Bungled Response to Complaints of Failures, FDA Says

  • Post author:Sam
  • Post published:October 9, 2017
  • Post category:The GMP Letter

A company that manufactures EpiPens neglected to follow up on hundreds of complaints that the epinephrine injectors failed to operate during life-threatening emergencies, including some that resulted in patients’ deaths…

Continue ReadingEpiPen Manufacturer Bungled Response to Complaints of Failures, FDA Says

FDA Launches Critical to Quality Pilot Program

  • Post author:Sam
  • Post published:October 9, 2017
  • Post category:The GMP Letter

The FDA rolled out its new Premarket Approval Application Critical to Quality pilot program, created to give PMA applicants the option to speak with the FDA on development of CtQ…

Continue ReadingFDA Launches Critical to Quality Pilot Program

DHS Flags Hacking Risk in Philips’ Radiation Monitoring App

  • Post author:Sam
  • Post published:September 12, 2017
  • Post category:The GMP Letter

The Department of Homeland Security issued an advisory over major software vulnerabilities in two versions of Philips Healthcare’s web application DoseWise Portal (DWP) that can give hackers access to protected…

Continue ReadingDHS Flags Hacking Risk in Philips’ Radiation Monitoring App

Good News, Bad News for BD: OK on Lead Tests, But Other Problems

  • Post author:Sam
  • Post published:September 12, 2017
  • Post category:The GMP Letter

The FDA said it could find no evidence that tubes made by Becton Dickinson for Magellan Diagnostics’ blood lead-level testing devices contributed to inaccurate readings from the devices, which Magellan…

Continue ReadingGood News, Bad News for BD: OK on Lead Tests, But Other Problems
  • Go to the previous page
  • 1
  • …
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • …
  • 44
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:

6042 Cornerstone Court W

Suite E

San Diego, CA 92121

Social:
© 2025 BioLegacy Research. All rights reserved.